NightHawk Biosciences Inc (NHWK)

[sirius22]

https://www.fda.gov/downloads/drugs/guidances/ucm153222.pdf

I'm new around here so sorry if this is old hat. I was looking around to see exactly what a type "C" meeting is with the FDA. Go figure that type C is seems somewhat ambiguous but much more positive than type A meetings. Type B meetings are definitely good from the looks of things such as discussing the issuance of and IND (initial drug discovery) or NDA (new drug application) license. NDA, if/once granted means you've been given the green light to start cooking up what you will eventually sell to the public, from what I learned in another stock. See ADMP and their generic to Mylan's epi-pen news in August as example of NDA approval example...